Association of miR-146a rs57095329 with Behçet’s disease and its complications

References

• Direskeneli H. Autoimmunity vs autoinflammation in Behçet’s disease: do we oversimplify a complex disorder? Rheumatology. 2006;45:1461–1465.
   PubMed Web of Science ®Google Scholar
• Ideguchi H, Suda A, Takeno M, et al. Behçet disease: evolution of clinical manifestations. Medicine. 2011;90:125–132.
   PubMed Web of Science ®Google Scholar
• Ceylan N, Bayraktaroglu S, Erturk SM, et al. Pulmonary and vascular manifestations of Behcet disease: imaging findings. Am J Roentgenol. 2010;194:W158–64.
   PubMed Web of Science ®Google Scholar
• De Menthon M, Lavalley MP, Maldini C, et al. HLA-B51/B5 and the risk of Behçet’s disease: A systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009;61:1287–1296.
   PubMed Web of Science ®Google Scholar
• Waller P, Blann AD. Non-coding RNAs – A primer for the laboratory scientist. Br J Biomed Sci. 2019;76:157–165.
   PubMed Web of Science ®Google Scholar
• Janssens S, Beyaert R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell. 2003;11:293–302.
   PubMed Web of Science ®Google Scholar
• Singh S, Rai G, Aggarwal A. Association of microRNA-146a and its target gene IRAK1 polymorphism with enthesitis related arthritis category of juvenile idiopathic arthritis. Rheumatology Int. 2014;34:1395–1400.
   PubMed Web of Science ®Google Scholar
• Ayeldeen G, Nassar Y, Ahmed H, et al. Possible use of miRNAs-146a and −499 expression and their polymorphisms as diagnostic markers for rheumatoid arthritis. Mol Cell Biochem. 2018;449:145–156.
   PubMed Web of Science ®Google Scholar
• Apparailly F. Looking for microRNA polymorphisms as new rheumatoid arthritis risk loci? Joint Bone Spine. 2010;77:377–379.
   PubMedGoogle Scholar
• Zhou Q, Hou S, Liang L, et al. MicroRNA-146a and Ets-1 gene polymorphisms in ocular Behçet’s disease and Vogt–Koyanagi–Harada syndrome. Ann Rheum Dis. 2014;73:170–176.
   PubMed Web of Science ®Google Scholar
• Davatchi F, Assaad-Khalil S, Calamia KT, et al. The international criteria for Behçet’s disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28:338–347.
   PubMed Web of Science ®Google Scholar
• Lawton G, Bhakta BB, Chamberlain MA, et al. The Behcet’s disease activity index. Rheumatology. 2004;43:73–78.
   PubMed Web of Science ®Google Scholar
• Pineton de Chambrun M, Wechsler B, Geri G, et al. New insights into the pathogenesis of Behcet’s disease. Autoimmun Rev. 2012;11:687–698.
   PubMed Web of Science ®Google Scholar
• Gheita TA, Gheita HA, Kenawy SA. The potential of genetically guided treatment in Behçet’s disease. Pharmacogenomics. 2016;17:1165–1174.
   PubMed Web of Science ®Google Scholar
• Lu J, Clark AG. Impact of microRNA regulation on variation in human gene expression. Genome Res. 2012;22:1243–1254.
   PubMed Web of Science ®Google Scholar
• Zhao ZZ, Croft L, Nyholt DR, et al. Evaluation of polymorphisms in predicted target sites for micro RNAs differentially expressed in endometriosis. Mol Hum Reprod. 2011;17:92–103.
   PubMed Web of Science ®Google Scholar
• Zeng L, Cui J, Wu H, et al. The emerging role of circulating microRNAs as biomarkers in autoimmune diseases. Autoimmunity. 2014;47:419–429.
   PubMed Web of Science ®Google Scholar
• Luo X, Yang W, Ye DQ, et al. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet. 2011;7:e1002128.
   PubMed Web of Science ®Google Scholar
• Jazdzewski K, Murray EL, Franssila K, et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2008;105:7269–7274.
   PubMed Web of Science ®Google Scholar
• Boldin MP, Baltimore D. MicroRNAs, new effectors and regulators of NF‐κB. Immunol Rev. 2012;246:205–220.
   PubMed Web of Science ®Google Scholar
• Ibrahim W, Sakr BR, Obaya E, et al. MicroRNA-146a expression and microRNA-146a rs2910164 polymorphism in Behçet’s disease patients. Clin Rheumatol. 2019;38:397–402.
   PubMed Web of Science ®Google Scholar
• Xie Y, Chu A, Feng Y, et al. MicroRNA-146a: a comprehensive indicator of inflammation and oxidative stress status induced in the brain of chronic T2DM rats. Front Pharmacol. 2018;9:478.
   PubMed Web of Science ®Google Scholar
• Wang HJ, Huang YL, Shih YY, et al. MicroRNA-146a decreases high glucose/thrombin-induced endothelial inflammation by inhibiting NADPH oxidase 4 expression. Mediators Inflamm. 2014;2014:379537.
   PubMed Web of Science ®Google Scholar
• Kolahi S, Farajzadeh MJ, Alipour S, et al. Determination of miR-155 and miR-146a expression rates and its association with expression level of TNF-α and CTLA4 genes in patients with Behçet’sdisease. Immunol Lets. 2018;204:55–59.
   Google Scholar
• Hou S, Ye Z, Liao D, et al. miR-23a, miR-146a and miR-301 confer predisposition to Vogt-Koyanagi-Harada syndrome but not to Behçet’s disease. Sci Reps. 2016;6. DOI:10.1038/srep20057.
   Web of Science ®Google Scholar
• Adeeb F, Stack AG, Fraser AD. Kitting the treads of silk through time: Behçet’s disease – past, present and future. Int J Rheumatol. 2017;2017:1–13.
   PubMed Web of Science ®Google Scholar